While India is experiencing the maximum peak of the Coronavirus pandemic, the United States is carrying out a vaccination campaign at an unprecedented level. The Food and Drug Administration (FDA) is even studying the possibility of authorizing the use of the Coronavirus vaccine from the pharmaceutical company Pfizer and BioNTech even for children and young people from 12 years old.
The ok for use on very young Americans should arrive next week.
The FDA had already authorized the Pfizer vaccine for young people over 16. The agency plans to approve Pfizer’s use of the vaccine for children under 12 years of age by the fall.
The United States is the country in the world with the largest number of infected people, with over 32 million registered cases but also the one with the most advanced vaccination. About 50% of the population has already received at least one first dose and about 100 million people, one third of the population, have completed the vaccination.
The US government has ordered the purchase of at least 300 million doses of iBioNTech-Pfizer by the end of July to vaccinate another 150 million people. However, one in five Americans say they won’t get vaccinated.
Last month Pfizer asked US authorities to authorize emergency use of its vaccine for teenagers aged 12 to 15 after conducting a study with 2,260 individuals that showed 100% effectiveness.
Pfizer is currently the only company that has asked to lower the age limit for vaccinated people.
By the middle of this year, Moderna is also expected to present its results on the very young.
Pfizer’s approval for children ages 12 to 15 will add millions of people to the vaccinated population in the United States, about 20 percent of the nation. Only with this immunized band will the country achieve herd immunity.
Last week, Ugur Sahin, co-founder of BioNTech announced that a third dose will be needed nine months or at most one year after the second, to reinforce protection against the Coronavirus. According to the scientist, immunity seems to decline over the months and that it will need to be reactivated with a third dose, and probably with subsequent doses every year or year and a half. Practically like seasonal flu.